S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
OTCMKTS:AXIM

AXIM Biotechnologies (AXIM) Stock Price, News & Analysis

$0.02
0.00 (0.00%)
(As of 04/15/2024 ET)
Today's Range
$0.0115
$0.0176
50-Day Range
$0.0103
$0.0193
52-Week Range
$0.01
$0.05
Volume
231,091 shs
Average Volume
442,339 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AXIM stock logo

About AXIM Biotechnologies Stock (OTCMKTS:AXIM)

AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

AXIM Stock Price History

AXIM Stock News Headlines

“Forget Tesla, this is Elon’s Next Big Thing”
According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.
Axim Fishermen Hail Govt
MASLOC Trial: Daniel Axim Denies Charges
“Forget Tesla, this is Elon’s Next Big Thing”
According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.
LLBO Lifeline Biotechnologies, Inc.
Axim Fishermen Plead For More Premix
AXIM - AXIM Biotechnologies, Inc.
See More Headlines
Receive AXIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AXIM Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/15/2024
Next Earnings (Estimated)
4/17/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:AXIM
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. John W. Huemoeller II (Age 69)
    President, CEO & Director
    Comp: $420k
  • Mr. Robert T. Malasek (Age 56)
    CFO & Secretary
    Comp: $90k
  • Ms. Catalina Valencia J.D. (Age 75)
    Co-Founder & CEO of Sapphire Biotech, Inc.
    Comp: $187.5k
  • Mr. Kurt Phinney (Age 52)
    Chief Operating Officer
  • Dr. Sergei A. Svarovsky M.B.A.
    Ph.D., Chief Scientific Officer & Co-Founder of Sapphire Biotech, Inc.
  • Dr. Alim Seit-Nebi Ph.D.
    CTO & Co-Founder of Sapphire Biotech, Inc.
  • Mr. Jeffrey A. Busby
    Senior Vice President of Business Development
  • Dr. Joseph Tauber M.D. (Age 67)
    Chief Medical Officer & Chairman of the Medical Advisory Board

AXIM Stock Analysis - Frequently Asked Questions

How have AXIM shares performed in 2024?

AXIM Biotechnologies' stock was trading at $0.0190 at the beginning of the year. Since then, AXIM shares have decreased by 17.9% and is now trading at $0.0156.
View the best growth stocks for 2024 here
.

When is AXIM Biotechnologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 17th 2024.
View our AXIM earnings forecast
.

What other stocks do shareholders of AXIM Biotechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AXIM Biotechnologies investors own include Cronos Group (CRON), Tilray (TLRY), KushCo (KSHB), Curaleaf (CURLF), Charlotte's Web (CWBHF), Fulcrum Therapeutics (FULC) and Alibaba Group (BABA).

How do I buy shares of AXIM Biotechnologies?

Shares of AXIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AXIM) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners